NorthWest Biotherapeutics Inc (NWBO)

[Maverick0408]

Correct. Even if they submitted their manuscript after the Lancet article came out on Oct 1 detailing the use of ECA (which LL and NWBO team would have anticipated given that Tim Cloughesy from UCLA was one of the authors), I would expect a publication by the end of this quarter.

Also, I still find it really strange that they wouldn’t update clinical trials website with the new end points. That still remains a bit of a concern for me. Hopefully their plan is to update it when FDA officially accepts their BLA.

The ideal situation would be TLD+publication+update to clinical trials website all within 24 hours this quarter, but we will see.